Cardiovascular Systems, Inc. Reports Fiscal 2017 First-Quarter Financial Results

Go back to Cardiovascular Systems, Inc. Reports Fiscal 2017 First-Quarter Financial Results

Feltl & Co Upgrades Cardiovascular Systems (CSII) to Strong Buy

October 27, 2016 9:54 AM EDT

Feltl & Co upgraded Cardiovascular Systems (NASDAQ: CSII) from Buy to Strong Buy with a price target of $30.

For an analyst ratings summary and ratings history on Cardiovascular Systems click here. For more ratings news on Cardiovascular Systems click here.

Shares of Cardiovascular Systems closed at $21.47 yesterday.

... More